July 23, 2025

Washington, D.C. — Earlier this week, Americans for Medical Progress (AMP) submitted written comments to the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) Public Forum 2025. This annual event brings together a range of stakeholders, including multiple federal agencies, to exchange information and advance efforts related to non-animal methods and the integration of the 3Rs (reduce, refine, replace) in both biomedical and toxicological research.

AMP’s comments builds on its previous feedback to the joint workshop organized by the Food and Drug Administration (FDA) and National Institutes of Health (NIH) earlier this month. Given ICCVAM’s role as a trusted convener and facilitator of discussions at the intersection of animal and non-animal research, AMP offered the following three recommendations:

1. Establish a standardized definition of NAMs;

2. Promote understanding of federal policy changes; and

3. Proactively engage with the veterinary and Institutional Animal Care and Use Committee (IACUC) community.

To further highlight these priorities, AMP also delivered oral comments during the forum.

Read AMP’s full public comments here. As the research landscape continues to evolve, AMP is committed to ensuring that the models we use and promote in biomedical research serve the science, not define it.